Journal
JOURNAL OF MOLECULAR ENDOCRINOLOGY
Volume 41, Issue 5-6, Pages 263-275Publisher
BIOSCIENTIFICA LTD
DOI: 10.1677/JME-08-0103
Keywords
-
Categories
Funding
- National Institutes of Health [ES04917]
Ask authors/readers for more resources
17 beta -Estradiol binds to the estrogen receptor (ER) to activate gene expression or repression and this involves both genomic (nuclear) and non-genomic (extranuclear) pathways. Genomic pathways include the classical interactions of ligand-bound ER dimers with estrogen-responsive elements in target gene promoters. ER-dependent activation of gene expression also involves DNA-bound ER that subsequently interacts with other DNA-bound transcriptions factors and direct ER-transcription factor (protein-protein) interactions where ER does not bind promoter DNA. Ligand-induced activation of ER/specificity protein (Sp) and ER/activating protein-1 [(AP-1); consisting of jun/fos] complexes are important pathways for modulating expression of a large number of genes. This review summarizes some of the characteristics of ER/Sp- and ER/AP-1-mediated transactivation, which are dependent on ligand structure, cell context, ER-subtype (ER alpha and ER beta), and Sp protein (SP1, SIP3, and SP4) and demonstrates that this non-classical genomic pathway is also functional in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available